Biophytis
@biophytis.com
Biophytis développe des traitements innovants pour ralentir le vieillissement et améliorer la santé durable. Découvrez notamment BIO 101.
Biophytis's Company Logos
Biophytis's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#00DC93
Caribbean Green
0, 220, 147
160, 100, 43
100, 0, 33, 14
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#757BAB
Kimberly
117, 123, 171
233, 24, 56
32, 28, 0, 33
About Biophytis
Biophytis is a clinical-stage biotechnology company specializing in the development of therapeutic products aimed at slowing down degenerative processes associated with aging. Their mission is to improve functional outcomes for patients with age-related diseases, including severe respiratory failure in COVID-19 patients. Biophytis focuses on targeting and activating key biological resilience pathways that can prevent and mitigate the effects of various biological and environmental stresses related to aging, such as inflammation, oxidation, metabolism, and genetics.
Their flagship product, Sarconeos (BIO101), is an orally administered small molecule for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy. Additionally, they have a second candidate, Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases such as dry age-related macular degeneration and Stargardt disease. With a commitment to innovation and research, Biophytis is dedicated to improving the quality of life for aging populations
Company type
Public Company
Year founded
2006
Company size
11-50 employees
Related Brands
Tags
AI-accelerated drug discovery platform
Longevity therapeutics
Clinical-stage drug candidate development
Sarcopenia drug program
Obesity treatment with GLP-1 combinations
